Fig. 3. EMP2 suppresses tumor formation. / EMP2 was recombinantly reintroduced into MV cells using a pSRα retroviral expression vector. Balb/c mice were injected intraperitoneally with 5 × 105 vector control or mEMP2 overexpressing cells. Mice were monitored for up to 50 days for tumor formation.
Fig. 3.

EMP2 suppresses tumor formation.

EMP2 was recombinantly reintroduced into MV cells using a pSRα retroviral expression vector. Balb/c mice were injected intraperitoneally with 5 × 105 vector control or mEMP2 overexpressing cells. Mice were monitored for up to 50 days for tumor formation.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal